NIKE Inc. (NKE)

NYSE: NKE · USD

$37.1

-0.45 (-1.2%)· Recorded snapshot

Engelse bronNL

Engelse bron wordt weergegeven terwijl we vertalen

Dit rapport is nog niet vertaald. Vernieuw over een paar minuten zodra de vertaalwachtrij is bijgewerkt.

StockMarketAgent Research · Analyzed 2026-10-11

Our latest published analysis: NKE rated Hold

NIKE Inc.'s published Hold conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.

Fair value

$31.9 / share

Potential value

$46.2 / share

Upside to FV

-8.0%

from $37.1

Moat

9/10

Wide

Read full analysis →View archive · 24mo

9-phase methodology · same model in each published edition

Market cap	$51.6B
Revenue (ttm)	45.9B
Net income (ttm)	3.1B
EPS (ttm)	$2.09
Shares out	1.5B
P/E (trailing)	17.8x
P/E (forward)	21.0x
Dividend	$1.64 (4.42%)
Volume	12,830,602
Beta	1.10

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 45.9B
Net income (ttm): 3.1B
EPS (ttm): $2.09
P/E (trailing): 17.8x
P/E (forward): 21.0x
Market cap: $51.6B

Item	P1	P2	P3	P4	P5	Trend
Period	2022-05-31	2023-05-31	2024-05-31	2025-05-31	2026-05-31	Trend
Revenue	$46.71B	$51.22B	$51.36B	$46.31B	$46.40B	-0.2%
Gross profit	$21.48B	$22.29B	$22.89B	$19.79B	$19.91B	-1.9%
Operating income	$6.94B	$6.48B	$6.96B	$4.17B	$3.80B	-14.0%
Net income	$6.05B	$5.07B	$5.70B	$3.22B	$3.11B	-15.3%
EPS (diluted)	$3.75	$3.23	$3.73	$2.16	$2.10	-13.5%
EBITDA	$7.78B	$7.34B	$7.81B	$4.98B	$4.54B	-12.6%
R&D	—	—	—	—	—	—
SG&A	$14.80B	$16.38B	$16.58B	$16.09B	$16.11B	+2.1%

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ABBV	AbbVie Inc.	505.6B	80.8x	7.9x	17.7%	+3.7%	+29.1%	Verkopen
ABT	Abbott Laboratories	177.6B	38.2x	3.7x	7.2%	+2.7%	-17.2%	Verminderen
ACN	Accenture plc	144.3B	18.0x	2.0x	27.9%	+8.0%	+0.4%	Aanhouden
ABNB	Airbnb, Inc.	97.8B	37.5x	7.4x	16.8%	+24.4%	+28.5%	Verkopen
AMZN	Amazon.com Inc.	2.7T	20.5x	3.5x	11.9%	+11.8%	+12.2%	Verkopen
APTV	Aptiv PLC	9.1B	42.8x	0.4x	7.8%	+5.5%	-49.2%	Kopen

Base and Bull scenarios

Base55%

Price target

$31.93

-8.0% from spot

The base case models FY2027 as a deliberate operational reset year characterized by high single-digit revenue contraction and trough operating margins of 6.8%,. As excess lifestyle inventories clear and wholesale re-orders normalize, top-line growth recovers to +2.5% in FY2028 and +4.5% in FY2029. Supply chain efficiencies from Pace steadily ramp, driving operating margin recovery by FY2031 and restoring sustainable economic value creation.

FY2027 revenue contracts -7.0% YoY, inflecting to +2.5% in FY2028, +4.5% in FY2029, +5.0% in FY2030, and +4.0% in FY2031
Operating margin bottoms at 6.8% in FY2027, recovering to 8.5% in FY2028, 9.8% in FY2029, 11.0% in FY2030, and 11.5% in FY2031
Effective tax rate held steady at 17.0%
Pace program generates $2.5B in cumulative gross savings through FY2031 with $1.0B in pre-tax restructuring charges
Terminal P/E multiple of 18.0x and terminal growth rate of 2.5%

Bull20%

Price target

$46.24

+33.2% from spot

In the bull case, the Sport Offense achieves rapid consumer adoption across running, basketball, and football, reclaiming market share from specialty entrants,. Wholesale partners aggressively restock core Nike franchises. Pace supply chain initiatives achieve early savings, driving consolidated operating margin back above prior peak levels and generating robust free cash flow that easily covers capital returns and debt obligations.

Accelerated recovery in wholesale orders with revenue expanding in FY2028 and accelerating annually thereafter
Pace restructuring program delivers gross savings ahead of schedule, expanding operating margin in FY2028 and through FY2031
Greater China revenue stabilizes rapidly and returns to high single-digit growth
EPS growth reaches 18% in FY2028, 14% in FY2029, and 10% in FY2030

Sensitivity: Ke × terminal growth

The highlighted cell is Fair value when every assumption sits at its base level ($31.93). Each row and column shows what Fair value becomes when one assumption moves.

Ke ↓ / g →	2.0%	2.3%	2.5%	2.8%	3.0%
8.6%	$33.7	$34.0	$34.4	$34.8	$35.3
9.1%	$32.5	$32.8	$33.1	$33.4	$33.8
9.6%	$31.4	$31.7	$31.9	$32.2	$32.5
10.1%	$30.5	$30.7	$30.9	$31.2	$31.4
10.6%	$29.6	$29.8	$30.0	$30.2	$30.4

Scorecard

Published factor rows and weighted composite

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E21

P25 n/aP50 n/aP75 n/a

Trailing P/E16.7

P25 n/aP50 n/aP75 n/a

ROE21.6

P25 n/aP50 n/aP75 n/a

ROIC18.9

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All NKE indicators

Market & fundamental data

Available fields

291

Groups with data

Currency

USD

Showing 291 of 291 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0000320187
Company name	NIKE, Inc.
Country	United States
Country code	US
CUSIP number	654106103
Earnings date	2026-12-17
Earnings time	amc
Employees	73,000
Employees change	-4,800
Employees growth	-6.17%
Enterprise value	$57.9B
Exchange	NYSE
Financial currency	USD
Financial report date	2026-08-31
First seen	2026-05-09
Fiscal year end	May
Founded	1964
In index	SP500, DOW30
Industry	Footwear & Accessories
IPO date	1980-12-12
Is primary listing	Yes
Is SPAC	No
ISIN number	US6541061031
Last 10-K release date	2026-07-15
Last earnings date	2026-10-01
Last refreshed	2026-10-28
Last stock split date	2015-12-24
Last stock split type	Forward
Market cap	$55.1B
Market cap category	Large-Cap
Next earnings date	2026-12-17
Options	Yes
Price	$37.11
Price currency	USD
Sector	Consumer Discretionary
SIC code	3021
Stock price date	2026-10-28
Symbol	NKE
U.S. state	Oregon
Website	https://www.nike.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	23.79x
Average P/E ratio (10Y)	36.63x
Average P/E ratio (3Y)	28.95x
Average P/E ratio (5Y)	30.67x
Earnings yield	5.63%
EV/Earnings	18.91x
EV/EBIT	14.12x
EV/EBITDA	11.95x
EV/FCF	27.78x
EV/Sales	1.27x
FCF / EV yield	3.6%
FCF yield	3.78%
Forward EV/Sales	1.38x
Forward P/E	28.73x
Forward P/S	1.31x
Graham number	21.95633
Graham upside	-41.48%
Industry forward P/E	18.79x
Industry P/E	16.25x
Lynch fair value	$10.44
Lynch upside	-72.18%
P/(FCF - SBC) ratio	39.33x
P/(OCF - SBC) ratio	26.63x
P/B ratio	3.66x
P/E ratio	17.77x
P/FCF ratio	26.47x
P/OCF ratio	20.04x
P/S ratio	1.21x
PEG ratio	5.82x
Price / tangible book value	3.79x
Price/EBITDA ratio	11.39x
Sector forward P/E	24.43x
Sector P/E	30.53x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	9.03%
EBITDA margin	10.66%
Effective tax rate	20.67%
FCF margin	4.59%
Gross margin	43.41%
Operating margin	9.03%
Pretax margin	8.5%
Profit margin	6.74%
Profit per employee	$42,370
Profitable quarters	25
Profitable years	33
Revenue per employee	$628,644
ROA	6.89%
ROA (5Y)	8.9%
ROCE	15.7%
ROE	21.56%
ROE (5Y)	32.65%
ROIC	18.86%
ROIC (5Y)	31.21%
SBC / revenue	1.5%
Tax / revenue	1.76%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	7.18%
EPS growth (Q)	-2.06%
EPS growth (QoQ)	-33.31%
EPS growth 10Y	-0.59%
EPS growth 3Y	-13.6%
EPS growth 5Y	-11.16%
EPS growth years	0
FCF growth	-30.04%
FCF growth 3Y	-22.14%
FCF growth 5Y	-19.39%
Gross profit growth	2.28%
Gross profit growth (Q)	-2.93%
Gross profit growth 3Y	-3.83%
Gross profit growth 5Y	-1.01%
Net income growth	6.84%
Net income growth (Q)	-2.06%
Net income growth (QoQ)	-33.4%
Net income growth 3Y	-15.09%
Net income growth 5Y	-12.65%
Net income growth years	0
OCF growth	-21.13%
OCF growth (Q)	-39.19%
OCF growth (QoQ)	-91.75%
OCF growth 10Y	-1.97%
OCF growth 3Y	-19.93%
OCF growth 5Y	-16.58%
Operating income growth	21.14%
Operating income growth (Q)	-4.21%
Operating income growth 3Y	-10.73%
Operating income growth 5Y	-11.4%
Revenue growth	-1.18%
Revenue growth (Q)	-4.33%
Revenue growth (QoQ)	2.2%
Revenue growth 10Y	3.35%
Revenue growth 3Y	-3.75%
Revenue growth 5Y	-0.13%
Revenue growth years	1

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-676M
Depreciation and amortization	$750M
EBIT	$4.1B
EBITDA	$4.9B
EPS	$2.09
FCF per share	$1.42
Financing cash flow	$-2.3B
Free cash flow	$2.1B
Free cash flow minus SBC	$1.4B
Gross profit	$19.9B
Income taxes	$806M
Investing cash flow	$-621M
Net cash flow	$-121M
Net income	$3.1B
Operating cash flow minus SBC	$2.1B
Operating income	$4.1B
Revenue	$45.9B
Stock-based compensation	$688M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	4.14
Book value per share	$10.26
Debt / EBITDA	1.84
Debt / equity	0.73
Debt / FCF	5.29
Goodwill	$240M
Interest coverage	18.83
Long-term assets	$14.1B
Long-term liabilities	$11.2B
Net cash (debt)	$-2.8B
Net cash / market cap	-4.95%
Net debt / EBITDA	0.56
Net debt / equity	0.18
Net debt / FCF	1.31
Piotroski F-Score	5
Property, plant and equipment	$7.8B
Shareholders' equity	$15.2B
Tangible book value	$14.7B
Tangible book value per share	$9.93
Total assets	$37.8B
Total cash	$8.4B
Total debt	$11.1B
Total liabilities	$22.6B
WACC	8.85%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	1.22
Current assets	$23.7B
Current liabilities	$11.4B
Current ratio	2.07
Inventory turnover	3.25
Net working capital	$6.4B
Quick ratio	1.19
Working capital	$12.3B
Working capital turnover	3.63

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-0.03%
Dividend growth	2.5%
Dividend growth (10Y)	9.87%
Dividend growth (3Y)	6.44%
Dividend growth (5Y)	8.32%
Dividend growth years	24
Dividend payment date	2026-10-01
Dividend payment years	43
Dividend payout frequency	Quarterly
Dividend per share	$1.64
Dividend yield	4.42%
Ex-dividend date	2026-09-01
FCF payout ratio	115.72%
Last dividend	$0.41
Payout ratio	78.56%
Shareholder yield	4.34%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-28.39%
10Y return CAGR	-1.87%
10Y total return	-17.18%
150-day SMA	$41.51
15Y price change	55.11%
15Y return CAGR	4.41%
15Y total return	91.05%
1D price change	-1.21%
1M price change	3.94%
1M total return	3.94%
1W price change	-1.9%
1W total return	-1.9%
1Y price change	-45.82%
1Y return CAGR	-44.06%
1Y total return	-44.04%
20-day SMA	$36.13
200-day SMA	$46.32
20Y price change	223.61%
20Y return CAGR	7.58%
20Y total return	331.01%
3M price change	-11.82%
3M total return	-10.88%
3Y price change	-62.07%
3Y return CAGR	-25.91%
3Y total return	-59.34%
50-day SMA	$37.03
50-day SMA vs 200-day SMA	50under200
52-week high	$69.14
52-week high date	2025-12-12
52-week low	$31.97
52-week low date	2026-10-02
5Y price change	-77.11%
5Y return CAGR	-24.17%
5Y total return	-74.91%
6M price change	-17.68%
6M total return	-16.06%
After-hours change	0.09%
After-hours close	$37.11
After-hours price	$37.14
All-time high	$179.10
All-time high date	2021-11-05
All-time low	$0.10
All-time low date	1984-10-31
Average true range (ATR)	$1.04
Average volume	37.7M
Beta (1Y)	0.87
Beta (2Y)	0.95
Beta (5Y)	1.1
Change from 52-week high	-46.33%
Change from 52-week low	16.06%
Change from all-time high	-79.25%
Change from all-time low	35,803.38%
Change from open	-0.12%
Day's gap	-1.09%
Dollar volume	$476.1M
High price	$37.61
Low price	$36.84
Monthly RSI	29.28
Open price	$37.15
Position in 52-week range	34.42%
Premarket change	-0.85%
Premarket close	$37.56
Premarket price	$37.24
Premarket volume	219.7K
Previous close	$37.56
Price vs 150-day SMA	-10.48%
Price vs 20-day SMA	2.86%
Price vs 200-day SMA	-19.78%
Price vs 50-day SMA	0.36%
Relative volume	0.34
RSI	52.79
Sharpe ratio	-1.55
Sharpe ratio (3Y)	-0.79
Sharpe ratio (5Y)	-0.69
Sortino ratio	-1.82
Sortino ratio (3Y)	-0.88
Sortino ratio (5Y)	-0.78
Volume	12.8M
Weekly RSI	37.33
YTD price change	-41.67%
YTD total return	-40.13%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1.2B
Float percentage	79.34%
Shares change (QoQ)	0.09%
Shares change (YoY)	0.03%
Shares held by insiders	20.1%
Shares held by institutions	65.8%
Shares outstanding	1.5B
Short % of float	8.42%
Short % of shares	6.68%
Short ratio	3 days

Other indicators

Additional ticker metrics that do not fit the primary research groupings.

Metric	Value
Page views	858

Deeper analysis on NKE

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Quote this valuation with its source: Fair value, Potential value and the price at analysis.

Frequently asked questions

About this NKE report

What is the latest published NKE stock rating?

NIKE Inc. is shown with Hold in the latest published report, analyzed 2026-10-11. The hub links directly to the full analysis surface where the dated rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full NKE analysis?

The full latest published report, analyzed 2026-10-11, lives at /stocks/NKE/analysis. The bare ticker page summarizes that read and links to each analysis tab; earlier editions remain under /analysis/archive.

What fair value is used for NKE?

The latest published report analyzed 2026-10-11 gives NKE a fair value of USD 32 and a potential value of USD 46. These are dated research outputs, not live market prices; review the valuation assumptions, sensitivity analysis, and material risks before making a decision.

How often is the NKE page updated?

The hub selects the latest published stock report regardless of age and displays its analysis date (2026-10-11). Separately sourced market data is labeled with its own recorded timestamp and is never inferred from the report.

HoldNKE · Fair value $31.9-8.0%

Read full analysis →

NIKE Inc. (NKE)

Our latest published analysis: NKE rated Hold

Price

Financial snapshot

Fair-value bridge

Latest news · NKE

Valuation

Profitability

Balance sheet

Trading

Base and Bull scenarios

Sensitivity: Ke × terminal growth

Scorecard

Next earnings

Sector percentile context

All NKE indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on NKE

Frequently asked questions

Ratinggeschiedenis

Category	Score	Reading
Valuation	4.5
Management	7.5
Balance Sheet	7.5
Profitability	6.0
Revenue Growth	2.5
Risk Assessment	7.0
Competitive Moat	9.0
Earnings Quality	6.0
Capital Efficiency	6.5